TrialJournal of neurology2025

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

W H Fung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.